December 2, 2025

Viridian Therapeutics, Inc. (VRDN): Investor Outlook with 25% Upside Potential in the Biotech Arena

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has been making waves in the biotechnology industry with its focus on developing groundbreaking treatments for serious and rare diseases. With a current market capitalization..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A 125% Potential Upside in the Biotech Sector

For savvy investors seeking high-growth opportunities in the biotech sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents a compelling case. With a market cap of $2.04 billion, the San Diego-based company..

ICU Medical, Inc. (ICUI) Stock Analysis: Unpacking a 23.67% Potential Upside for Investors

ICU Medical, Inc. (NASDAQ: ICUI), a notable player in the healthcare sector, primarily engages in the development and manufacturing of medical devices for infusion therapy, vascular access, and vital care..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a 14% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a compelling case with a potential upside of 14.27%. Specializing in medical instruments and supplies, Azenta operates..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Biotech Gem with 95.70% Potential Upside

Ocular Therapeutix, Inc. (OCUL), a leading biopharmaceutical company in the United States, is attracting significant attention from investors in the healthcare sector. With a robust market capitalization of $2.49 billion,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Can a 186% Upside Potential Excite Investors?

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the biotechnology landscape with its focus on developing innovative therapies for rare diseases. Headquartered in Durham, North Carolina, BioCryst is known for..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: A Healthcare Innovator with 66% Potential Upside

Investors with a keen interest in the healthcare sector may find Pulse Biosciences, Inc. (NASDAQ: PLSE) an intriguing prospect. The company, known for its pioneering work in bioelectric medicine, presents..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Analyst Ratings Indicate a 26% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. Based in Bothell, Washington, this innovative company is..

Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a Potential 58.8% Upside for Healthcare Investors

Ardent Health, Inc. (ARDT) is a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, the company operates an extensive network of..

Viking Therapeutics, Inc. (VKTX) Stock Report: A 170% Potential Upside Awaits in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX), a San Diego-based biotechnology company, has captured the attention of investors with its ambitious pipeline and a remarkable potential upside of 170.30%. Specializing in developing..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A 66.93% Potential Upside Awaits Investors

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, is gaining the attention of investors with its promising therapeutic developments and substantial growth potential. With a market..

Veracyte, Inc. (VCYT) Stock Analysis: Evaluating Growth Potential in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is a noteworthy player in the healthcare sector, specifically in diagnostics and research. With a market capitalization of $3.67 billion, Veracyte has carved out a niche..

Kestra Medical Technologies (KMTS) Stock Report: Revenue Growth Soars Amidst Healthcare Innovation

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a promising player in the healthcare sector, is turning heads with its impressive revenue growth and innovative solutions in the realm of cardiovascular disease..

LivaNova PLC (LIVN) Stock Analysis: A Promising Upside with Strategic Neuromodulation Focus

LivaNova PLC (NASDAQ: LIVN) has been steadily carving out a niche in the healthcare sector with its innovative medical devices tailored for neurological and cardiac conditions. With a market capitalization..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Promising Biotech with a 20.65% Return on Equity

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a key player in the biotechnology industry, continues to capture investor attention with its strategic focus on addressing unmet medical needs in autoimmune diseases. With..

Innoviva, Inc. (INVA) Stock Analysis: A 52% Upside Potential and Strategic Partnerships in Focus

Innoviva, Inc. (NASDAQ: INVA) is a name that has been making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.58 billion, this U.S.-based..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 90% Potential Upside in the Biotech Sector

For investors seeking opportunities within the biotechnology sector, Vera Therapeutics, Inc. (NASDAQ: VERA) presents an intriguing proposition, particularly with its impressive potential upside of 90.44%. Based in Brisbane, California, this..

PROCEPT BioRobotics (PRCT) Investor Outlook: Exploring a 71% Potential Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a leading innovator in the medical devices industry, is capturing investor attention with its significant growth potential, underscored by an impressive 71% potential upside from..

Alvotech (ALVO) Stock Analysis: A Look at the 445% Potential Upside in the Healthcare Sector

Alvotech (NASDAQ: ALVO), a burgeoning player in the specialty and generic drug manufacturing industry, is capturing investor attention with its substantial potential upside. Based in Luxembourg, this healthcare company is..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 145% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is making waves in the biopharmaceutical landscape with its strategic focus on rare and ultra-rare genetic diseases. Headquartered in Novato, California, this biotechnology company has..

Search

Funds

December 2, 2025

Search

Funds

December 2, 2025

FTSE 100

Funds